BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Suzuki H, Toyoda M, Horiguchi N, Kakizaki S, Ohyama T, Takizawa D, Ichikawa T, Sato K, Takagi H, Mori M. Hepatocyte growth factor protects against Fas-mediated liver apoptosis in transgenic mice. Liver International 2009;29:1562-8. [DOI: 10.1111/j.1478-3231.2009.02102.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Motoi S, Toyoda H, Obara T, Ohta E, Arita Y, Negishi K, Moriya K, Kuboi Y, Soejima M, Imai T, Ido A, Tsubouchi H, Kawano T. Anti-Apoptotic Effects of Recombinant Human Hepatocyte Growth Factor on Hepatocytes Were Associated with Intrahepatic Hemorrhage Suppression Indicated by the Preservation of Prothrombin Time. Int J Mol Sci 2019;20:E1821. [PMID: 31013780 DOI: 10.3390/ijms20081821] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
2 Kanuri G, Spruss A, Wagnerberger S, Bischoff SC, Bergheim I. Fructose-induced steatosis in mice: role of plasminogen activator inhibitor-1, microsomal triglyceride transfer protein and NKT cells. Lab Invest 2011;91:885-95. [PMID: 21423135 DOI: 10.1038/labinvest.2011.44] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
3 Kato T. Biological roles of hepatocyte growth factor-Met signaling from genetically modified animals. Biomed Rep 2017;7:495-503. [PMID: 29188052 DOI: 10.3892/br.2017.1001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
4 Wu Z, Han M, Chen T, Yan W, Ning Q. Acute liver failure: mechanisms of immune-mediated liver injury: Acute liver failure. Liver International 2010;30:782-94. [DOI: 10.1111/j.1478-3231.2010.02262.x] [Cited by in Crossref: 148] [Cited by in F6Publishing: 150] [Article Influence: 12.3] [Reference Citation Analysis]
5 Liu L, Jin M, Tao Q, Yu L, Du J, Wang C, Luo Q, Xing T, Xu Y, Shen J, Chu D. Effective Amelioration of Liver Fibrosis Through Lentiviral Vector Carrying Toxoplasma gondii gra15II in Murine Model. Front Immunol 2018;9:1572. [PMID: 30034399 DOI: 10.3389/fimmu.2018.01572] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
6 Moreno-Càceres J, Fabregat I. Apoptosis in liver carcinogenesis and chemotherapy. Hepat Oncol 2015;2:381-97. [PMID: 30191019 DOI: 10.2217/hep.15.27] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
7 Liu Z, Li Q, Shen R, Ci L, Wan Z, Shi J, Huang Q, Yang X, Zhang M, Yang H, Sun R, Wang Z, Huang F, Lu T, Fei J. Betaine/GABA transporter-1 (BGT-1) deficiency in mouse prevents acute liver failure in vivo and hepatocytes apoptosis in vitro. Biochim Biophys Acta Mol Basis Dis 2020;1866:165634. [PMID: 31830527 DOI: 10.1016/j.bbadis.2019.165634] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
8 Kanuri G, Ladurner R, Skibovskaya J, Spruss A, Königsrainer A, Bischoff SC, Bergheim I. Expression of toll-like receptors 1-5 but not TLR 6-10 is elevated in livers of patients with non-alcoholic fatty liver disease. Liver Int. 2015;35:562-568. [PMID: 24351080 DOI: 10.1111/liv.12442] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
9 Irshad M, Gupta P, Irshad K. Immunopathogenesis of Liver Injury During Hepatitis C Virus Infection. Viral Immunol 2019;32:112-20. [PMID: 30817236 DOI: 10.1089/vim.2018.0124] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
10 Kruitwagen HS, Arends B, Spee B, Brinkhof B, van den Ingh TS, Rutten VP, Penning LC, Roskams T, Rothuizen J. Recombinant hepatocyte growth factor treatment in a canine model of congenital liver hypoplasia. Liver Int 2011;31:940-9. [PMID: 21733083 DOI: 10.1111/j.1478-3231.2011.02513.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
11 Wang L, Li S, Wang HY, Zeng J, Zhang ZZ, Lv DY, Kuang WH. In a Rat Model of Acute Liver Failure, Icaritin Improved the Therapeutic Effect of Mesenchymal Stem Cells by Activation of the Hepatocyte Growth Factor/c-Met Pathway. Evid Based Complement Alternat Med 2019;2019:4253846. [PMID: 31915446 DOI: 10.1155/2019/4253846] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
12 Wang H, Zhao T, Xu F, Li Y, Wu M, Zhu D, Cong X, Liu Y. How important is differentiation in the therapeutic effect of mesenchymal stromal cells in liver disease? Cytotherapy. 2014;16:309-318. [PMID: 24239106 DOI: 10.1016/j.jcyt.2013.07.011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
13 Wencel A, Ciezkowska M, Wisniewska M, Zakrzewska KE, Pijanowska DG, Pluta KD. Effects of genetically modified human skin fibroblasts, stably overexpressing hepatocyte growth factor, on hepatic functions of cocultured C3A cells. Biotechnol Bioeng 2021;118:72-81. [PMID: 32880912 DOI: 10.1002/bit.27551] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]